These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
470 related items for PubMed ID: 26020100
1. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells. Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed ME. Mol Pharm; 2015 Jul 06; 12(7):2406-17. PubMed ID: 26020100 [Abstract] [Full Text] [Related]
2. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles. Kaushal N, Tiruchinapally G, Durmaz YY, Bao L, Gilani R, Merajver SD, ElSayed MEH. J Control Release; 2018 Nov 10; 289():79-93. PubMed ID: 30149048 [Abstract] [Full Text] [Related]
3. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Pillé JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C, Soria C, Li H. Mol Ther; 2005 Feb 10; 11(2):267-74. PubMed ID: 15668138 [Abstract] [Full Text] [Related]
4. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD. Cancer; 2010 Jun 01; 116(11 Suppl):2768-82. PubMed ID: 20503409 [Abstract] [Full Text] [Related]
5. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC. Wu D, Asiedu M, Wei Q. Oncogene; 2009 Jun 04; 28(22):2219-30. PubMed ID: 19421144 [Abstract] [Full Text] [Related]
6. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Simpson KJ, Dugan AS, Mercurio AM. Cancer Res; 2004 Dec 01; 64(23):8694-701. PubMed ID: 15574779 [Abstract] [Full Text] [Related]
7. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells. Wang L, Yang L, Luo Y, Zheng Y. J Biol Chem; 2003 Nov 07; 278(45):44617-25. PubMed ID: 12939257 [Abstract] [Full Text] [Related]
8. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration. Casteel DE, Turner S, Schwappacher R, Rangaswami H, Su-Yuo J, Zhuang S, Boss GR, Pilz RB. J Biol Chem; 2012 Nov 02; 287(45):38367-78. PubMed ID: 22992742 [Abstract] [Full Text] [Related]
9. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. Bourguignon LY, Wong G, Earle C, Krueger K, Spevak CC. J Biol Chem; 2010 Nov 19; 285(47):36721-35. PubMed ID: 20843787 [Abstract] [Full Text] [Related]
10. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells. Zuo Y, Wu Y, Chakraborty C. J Cell Physiol; 2012 Apr 19; 227(4):1399-407. PubMed ID: 21618528 [Abstract] [Full Text] [Related]
11. RhoC is essential for the metastasis of gastric cancer. Liu N, Zhang G, Bi F, Pan Y, Xue Y, Shi Y, Yao L, Zhao L, Zheng Y, Fan D. J Mol Med (Berl); 2007 Oct 19; 85(10):1149-56. PubMed ID: 17549441 [Abstract] [Full Text] [Related]
12. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition. Yang H, Liang J, Zhou J, Mi J, Ma K, Fan Y, Ning J, Wang C, Wei X, Li E. Mol Med Rep; 2016 Jun 19; 13(6):5255-61. PubMed ID: 27108649 [Abstract] [Full Text] [Related]
13. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Wang W, Wu F, Fang F, Tao Y, Yang L. Clin Cancer Res; 2008 Nov 01; 14(21):6804-12. PubMed ID: 18980974 [Abstract] [Full Text] [Related]
14. [Correlation of expression of RhoC with invasiveness of breast cancer cells in vitro]. Yuan Z, Su J, You JF, Wang JL, Cui XL, Zheng J. Zhonghua Zhong Liu Za Zhi; 2007 Dec 01; 29(12):898-903. PubMed ID: 18478927 [Abstract] [Full Text] [Related]
15. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer. Menezes ME, Shen XN, Das SK, Emdad L, Sarkar D, Fisher PB. Oncotarget; 2016 Dec 06; 7(49):80175-80189. PubMed ID: 27863394 [Abstract] [Full Text] [Related]
16. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Mol Cancer; 2005 Jun 21; 4(1):21. PubMed ID: 15969750 [Abstract] [Full Text] [Related]
17. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity. Dietrich KA, Schwarz R, Liska M, Grass S, Menke A, Meister M, Kierschke G, Längle C, Genze F, Giehl K. Biol Chem; 2009 Oct 21; 390(10):1063-77. PubMed ID: 19642867 [Abstract] [Full Text] [Related]
18. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway. Sun HW, Tong SL, He J, Wang Q, Zou L, Ma SJ, Tan HY, Luo JF, Wu HX. World J Gastroenterol; 2007 Jul 07; 13(25):3517-22. PubMed ID: 17659701 [Abstract] [Full Text] [Related]
19. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho. Kusama T, Mukai M, Tatsuta M, Nakamura H, Inoue M. Int J Oncol; 2006 Jul 07; 29(1):217-23. PubMed ID: 16773203 [Abstract] [Full Text] [Related]
20. The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells. Tseliou M, Al-Qahtani A, Alarifi S, Alkahtani SH, Stournaras C, Sourvinos G. Cell Physiol Biochem; 2016 Jul 07; 38(1):94-109. PubMed ID: 26741994 [Abstract] [Full Text] [Related] Page: [Next] [New Search]